Shopping Cart
- Remove All
- Your shopping cart is currently empty
Bifeprunox is a potent partial agonist of dopamine D2-like and 5-HT1A receptor (pEC50: 6.37 for hippocampus 5-HT1A; pKis: 7.19 and 8.83 for cortex 5-HT1A and striatum D2). It is an antipsychotic for the research of schizophrenia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | Bifeprunox is a potent partial agonist of dopamine D2-like and 5-HT1A receptor (pEC50: 6.37 for hippocampus 5-HT1A; pKis: 7.19 and 8.83 for cortex 5-HT1A and striatum D2). It is an antipsychotic for the research of schizophrenia. |
Targets&IC50 | D2 receptor:8.83 (pKi), 5-HT1A receptor:6.37(pEC50), 5-HT1A receptor:7.19 (pKi) |
In vitro | Bifeprunox has a pKi of 8 at h5-HT1A receptors (Emax: 70%) [1]. |
In vivo | Bifeprunox (0.001-2.5 mg/kg) reduces marble burying in mice [2] and (4-250 μg/kg) alters nicotine-seeking behavior in response to drug-associated stimuli in rats [3]. |
Molecular Weight | 385.46 |
Formula | C24H23N3O2 |
Cas No. | 350992-10-8 |
Relative Density. | 1.247g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.